Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COGNEX CORPCGNX · Entity 3527 | VP and PAO | May 11, 2026 | May 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COGNEX CORP
Report date May 11, 2026 · Filed May 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,258 |
Ending reported balance
After 2026-05-12 transaction · row 19
19 source rows · reconciled sequenceRow 1 · 2026-05-11 · Exercise / conversion · Acquired 6,634 · Balance 14,104 Row 2 · 2026-05-11 · Sale · Disposed 6,634 · Balance 7,470 Row 3 · 2026-05-11 · Exercise / conversion · Acquired 15,080 · Balance 22,550 Row 4 · 2026-05-11 · Sale · Disposed 15,080 · Balance 7,470 Row 5 · 2026-05-11 · Exercise / conversion · Acquired 12,196 · Balance 19,666 Row 6 · 2026-05-11 · Sale · Disposed 12,196 · Balance 7,470 Row 7 · 2026-05-11 · Exercise / conversion · Acquired 17,000 · Balance 24,470 Row 8 · 2026-05-11 · Sale · Disposed 17,000 · Balance 7,470 Row 9 · 2026-05-11 · Exercise / conversion · Acquired 30,000 · Balance 37,470 Row 10 · 2026-05-11 · Sale · Disposed 30,000 · Balance 7,470 Row 11 · 2026-05-11 · Exercise / conversion · Acquired 15,000 · Balance 22,470 Row 12 · 2026-05-11 · Sale · Disposed 15,000 · Balance 7,470 Row 13 · 2026-05-11 · Sale · Disposed 2,212 · Balance 5,258 Row 14 · 2026-05-12 · Exercise / conversion · Acquired 6,100 · Balance 11,358 Row 15 · 2026-05-12 · Sale · Disposed 6,100 · Balance 5,258 Row 16 · 2026-05-12 · Exercise / conversion · Acquired 10,000 · Balance 15,258 Row 17 · 2026-05-12 · Sale · Disposed 10,000 · Balance 5,258 Row 18 · 2026-05-12 · Exercise / conversion · Acquired 25,500 · Balance 30,758 Row 19 · 2026-05-12 · Sale · Disposed 25,500 · Balance 5,258 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.04 · Expires 2035-02-18 | Direct | 26,534 |
Reported balance
After 2026-05-11 transaction · row 21
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 21 · 2026-05-11 · Exercise / conversion · Disposed 6,634 · Balance 26,534 F2: The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2025). |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.44 · Expires 2034-02-20 | Direct | 22,618 |
Reported balance
After 2026-05-11 transaction · row 22
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 22 · 2026-05-11 · Exercise / conversion · Disposed 15,080 · Balance 22,618 F3: The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 20, 2024). |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.21 · Expires 2033-02-21 | Direct | 18,296 |
Reported balance
After 2026-05-11 transaction · row 23
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 23 · 2026-05-11 · Exercise / conversion · Disposed 12,196 · Balance 18,296 F4: The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 21, 2023). |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.21 · Expires 2033-02-21 | Direct | 12,196 |
Reported balance
After 2026-05-12 transaction · row 24
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 24 · 2026-05-12 · Exercise / conversion · Disposed 6,100 · Balance 12,196 F4: The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 21, 2023). |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $48.28 · Expires 2029-05-01 | Direct | 0 |
Reported balance
After 2026-05-12 transaction · row 25
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 25 · 2026-05-12 · Exercise / conversion · Disposed 10,000 · Balance 0 F5: The options vest 100% on the third anniversary of the grant date (May 1, 2019). |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $50.94 · Expires 2030-02-18 | Direct | 25,500 |
Reported balance
After 2026-05-11 transaction · row 26
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 26 · 2026-05-11 · Exercise / conversion · Disposed 17,000 · Balance 25,500 F6: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2020). |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $50.94 · Expires 2030-02-18 | Direct | 0 |
Reported balance
After 2026-05-12 transaction · row 27
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 27 · 2026-05-12 · Exercise / conversion · Disposed 25,500 · Balance 0 F6: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2020). |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $51.49 · Expires 2029-02-19 | Direct | 0 |
Reported balance
After 2026-05-11 transaction · row 28
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 28 · 2026-05-11 · Exercise / conversion · Disposed 30,000 · Balance 0 F7: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 19, 2019). |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $56.44 · Expires 2028-02-20 | Direct | 0 |
Reported balance
After 2026-05-11 transaction · row 29
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 29 · 2026-05-11 · Exercise / conversion · Disposed 15,000 · Balance 0 F8: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 20, 2018). |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $57.09 · Expires 2036-02-17 | Direct | 7,231 |
Reported balance
Holding disclosure · report date 2026-05-11 · row 30
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 30 · Balance 7,231 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $64.43 · Expires 2032-02-22 | Direct | 23,891 |
Reported balance
Holding disclosure · report date 2026-05-11 · row 31
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 31 · Balance 23,891 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $90.50 · Expires 2031-02-16 | Direct | 13,946 |
Reported balance
Holding disclosure · report date 2026-05-11 · row 32
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 32 · Balance 13,946 |
| Common StockSEC Table I · non-derivative | IndirectBy Child | 20 |
Reported balance
Holding disclosure · report date 2026-05-11 · row 20
Holding and transaction disclosures are not merged.
1 source rowRow 20 · Balance 20 F1: Held by reporting person's child. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-02-20 | Direct | 3,169 |
Reported balance
Holding disclosure · report date 2026-05-11 · row 33
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 33 · Balance 3,169 |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-03-15 | Direct | 614 |
Reported balance
Holding disclosure · report date 2026-05-11 · row 34
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 34 · Balance 614 |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2028-02-18 | Direct | 9,685 |
Reported balance
Holding disclosure · report date 2026-05-11 · row 35
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 35 · Balance 9,685 |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2029-02-17 | Direct | 11,211 |
Reported balance
Holding disclosure · report date 2026-05-11 · row 36
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 36 · Balance 11,211 |
Filing footnotes · ownership attribution and instrument terms
F1: Held by reporting person's child. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
F2: The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2025).
F3: The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 20, 2024).
F4: The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 21, 2023).
F5: The options vest 100% on the third anniversary of the grant date (May 1, 2019).
F6: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2020).
F7: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 19, 2019).
F8: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 20, 2018).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2025 Filed Feb 24, 2025 21:35 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionRestricted Stock Unit · Derivative | 2,072 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001829813-25-000010 · edgardoc.xml · derivative · entry 8 MACDONALD LAURA ANN · CIK 0001773704 · PFO & PAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,072 shares Expires 2025-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F6 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 22, 2022), respectively. Read SEC document |
| February 22, 2025 Filed Feb 24, 2025 21:35 UTC | COGNEX CORP CGNX · Entity 3527 | Tax withholdingCommon Stock | 658 | $32.78 | $21,569.24 |
DisclosureSEC source: 0001829813-25-000010 · edgardoc.xml · nonDerivative · entry 6 MACDONALD LAURA ANN · CIK 0001773704 · PFO & PAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,086 F3 · kind: This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 22, 2025 and are reported herein. Read SEC document |
| February 22, 2025 Filed Feb 24, 2025 21:35 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 2,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001829813-25-000010 · edgardoc.xml · nonDerivative · entry 5 MACDONALD LAURA ANN · CIK 0001773704 · PFO & PAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2025 Filed Feb 24, 2025 21:35 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionRestricted Stock Unit · Derivative | 1,652 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001829813-25-000010 · edgardoc.xml · derivative · entry 9 MACDONALD LAURA ANN · CIK 0001773704 · PFO & PAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,754 Underlying: Common Stock · 1,652 shares Expires 2026-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F7 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively. Read SEC document |
| February 21, 2025 Filed Feb 24, 2025 21:35 UTC | COGNEX CORP CGNX · Entity 3527 | Tax withholdingCommon Stock | 573 | $32.78 | $18,782.94 |
DisclosureSEC source: 0001829813-25-000010 · edgardoc.xml · nonDerivative · entry 4 MACDONALD LAURA ANN · CIK 0001773704 · PFO & PAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,672 F2 · kind: This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 21, 2025 and are reported herein. Read SEC document |
| February 21, 2025 Filed Feb 24, 2025 21:35 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 1,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001829813-25-000010 · edgardoc.xml · nonDerivative · entry 3 MACDONALD LAURA ANN · CIK 0001773704 · PFO & PAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,245 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:35 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionRestricted Stock Unit · Derivative | 1,268 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001829813-25-000010 · edgardoc.xml · derivative · entry 10 MACDONALD LAURA ANN · CIK 0001773704 · PFO & PAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,071 Underlying: Common Stock · 1,268 shares Expires 2027-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F8 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 20, 2024), respectively. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:35 UTC | COGNEX CORP CGNX · Entity 3527 | Tax withholdingCommon Stock | 440 | $33.40 | $14,696.00 |
DisclosureSEC source: 0001829813-25-000010 · edgardoc.xml · nonDerivative · entry 2 MACDONALD LAURA ANN · CIK 0001773704 · PFO & PAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,593 F1 · kind: This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 20, 2025 and are reported herein. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:35 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 1,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001829813-25-000010 · edgardoc.xml · nonDerivative · entry 1 MACDONALD LAURA ANN · CIK 0001773704 · PFO & PAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,033 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:13 UTC | COGNEX CORP CGNX · Entity 3527 | GrantRestricted Stock Unit · Derivative | 12,107 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001721515-25-000012 · edgardoc.xml · derivative · entry 4 MACDONALD LAURA ANN · CIK 0001773704 · PFO & PAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,107 Underlying: Common Stock · 12,107 shares Expires 2028-02-18 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F4 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 18, 2025), respectively. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:13 UTC | COGNEX CORP CGNX · Entity 3527 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 33,168 | $0.00 Strike: $33.04 | $0.00 |
DisclosureSEC source: 0001721515-25-000012 · edgardoc.xml · derivative · entry 3 MACDONALD LAURA ANN · CIK 0001773704 · PFO & PAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,168 Underlying: Common Stock · 33,168 shares Expires 2035-02-18 F2 · derivative.exercise_date: The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2025). Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 22:13 UTC | COGNEX CORP CGNX · Entity 3527 | GrantRestricted Stock Unit · Derivative | 1,228 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001773704-24-000003 · edgardoc.xml · derivative · entry 3 MACDONALD LAURA ANN · CIK 0001773704 · PFO & PAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,228 Underlying: Common Stock · 1,228 shares Expires 2027-03-15 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (March 15, 2024), respectively. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 15:50 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $16.72 | $0.00 |
DisclosureSEC source: 0001773704-20-000002 · edgardoc.xml · derivative · entry 3 MACDONALD LAURA ANN · CIK 0001773704 · Principal Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 11,000 shares Expires 2026-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 15:50 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 11,000 | $52.45 | $576,988.50 |
DisclosureSEC source: 0001773704-20-000002 · edgardoc.xml · nonDerivative · entry 2 MACDONALD LAURA ANN · CIK 0001773704 · Principal Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 15:50 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 11,000 | $16.72 | $183,920.00 |
DisclosureSEC source: 0001773704-20-000002 · edgardoc.xml · nonDerivative · entry 1 MACDONALD LAURA ANN · CIK 0001773704 · Principal Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 22:04 UTC | COGNEX CORP CGNX · Entity 3527 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 42,500 | $0.00 Strike: $50.94 | $0.00 |
DisclosureSEC source: 0001136883-20-000004 · edgardoc.xml · derivative · entry 1 MACDONALD LAURA ANN · CIK 0001773704 · Principal Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,500 Underlying: Common Stock · 42,500 shares Expires 2030-02-18 Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 13:22 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $20.63 | $0.00 |
DisclosureSEC source: 0001773704-19-000002 · edgardoc.xml · derivative · entry 3 MACDONALD LAURA ANN · CIK 0001773704 · Principal Financial Officer & 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,000 shares Expires 2025-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 13:22 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 24,000 | $51.35 | $1,232,373.60 |
DisclosureSEC source: 0001773704-19-000002 · edgardoc.xml · nonDerivative · entry 2 MACDONALD LAURA ANN · CIK 0001773704 · Principal Financial Officer & 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 13:22 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 24,000 | $20.63 | $495,000.00 |
DisclosureSEC source: 0001773704-19-000002 · edgardoc.xml · nonDerivative · entry 1 MACDONALD LAURA ANN · CIK 0001773704 · Principal Financial Officer & 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.